SeaBridge Investment Advisors LLC Makes New $806,000 Investment in iShares Biotechnology ETF (NASDAQ:IBB)

SeaBridge Investment Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 6,093 shares of the financial services provider’s stock, valued at approximately $806,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of IBB. BNP Paribas Financial Markets boosted its holdings in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares in the last quarter. Aprio Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth $18,476,000. Sanctuary Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF during the second quarter worth $8,118,000. Finally, DRW Securities LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter valued at $5,990,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $138.66 on Friday. The business’s 50-day moving average price is $136.37 and its 200 day moving average price is $141.63. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.